Mylan CEO Must Face New EpiPen Deposition, Judge Rules
Consumers can depose Mylan Inc.'s CEO again in multidistrict litigation over EpiPen price hikes because new and "highly relevant" information has surfaced about potential maneuvers to block lower-cost competition, a Kansas...To view the full article, register now.
Already a subscriber? Click here to view full article